Belite Bio, Inc. Sponsored ADR (BLTE)

Last Closing Price: 165.45 (2026-04-17)

Return on Tangible Equity (Quarterly)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Belite Bio, Inc. Sponsored ADR (BLTE) had Return on Tangible Equity of -3.29% for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
$-25.32M
--
--
$28.08M
$-28.08M
$2.75M
$-25.32M
$-25.32M
$-25.32M
$-25.32M
$-25.32M
$-25.32M
$-28.08M
$-27.96M
33.54M
33.54M
$-0.71
$-0.71
Balance Sheet Financials
$494.27M
$0.34M
$286.28M
$780.56M
$9.88M
--
$0.19M
$10.07M
$770.49M
$770.47M
$770.49M
39.34M
Cash Flow Statement Financials
$-36.99M
$-305.11M
$663.23M
$31.68M
$352.93M
$321.25M
$38.92M
--
--
Fundamental Metrics & Ratios
50.02
--
--
--
--
--
--
--
--
--
--
$-37.17M
--
--
--
--
--
--
--
-3.29%
Return on Tangible Equity
-3.29%
-3.24%
-3.29%
$19.59
$-1.11
$-1.10